Clover Health (CLOV) CEO Wai Conrad Sells 300,000 Shares

What Happened Wai Conrad, CEO of Clover Health Investments, sold 300,000 shares (disposed) on September 15, 2026, for aggregate proceeds of approximately $1,416,000. The filing lists the transaction as an open-market or private sale with a weighted average price of $4.72 per share. This was a sale (not a purchase), which is commonly routine insider selling.

Key Details

• Transaction date: 2026-09-15; Form 4 filed 2026-09-16 (timely).
• Shares sold: 300,000; weighted average price: $4.72; total proceeds: $1,416,000.
• Price range: shares were sold in multiple trades at prices between $4.60 and $5.06 (inclusive).
• Shares owned after the transaction: not disclosed on this Form 4.
• Footnotes: Sale effected under a Rule 10b5-1 trading plan adopted June 8, 2026 (Reporting Person will provide breakdown of sales by price on request). Some shares are held in trust for the reporting person’s family, of which the reporting person is a co-trustee.

Context A 10b5-1 plan indicates the trades were executed under a pre-established schedule or instructions and are typically treated as planned transactions rather than ad hoc trades based on current nonpublic information. Sales do not necessarily signal a change in company outlook; they may reflect personal liquidity or diversification needs.